Concepedia

Expression of Excision Repair Cross-Complementation Group 1 as Predictive Marker for Nasopharyngeal Cancer Treated With Concurrent Chemoradiotherapy

Jong‐Mu Sun, Myung‐Ju Ahn, Min Jae Park, Hui‐Young Lee, Jin Seok Ahn, Seungkoo Lee, Gu Hyum Kang, Joungho Han, Young‐Ik Son, Chung‐Hwan Baek,

International Journal of Radiation Oncology*Biology*Physics · 2011 · 43 citations · 28 references

DOI

Concepts

References

28

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Muhyi Al‐Sarraf, Michael LeBlanc, Padmini Giri et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

, , +13

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Ken A. Olaussen, Ariane Dunant, Pierre Fouret et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

, , +16

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

Jin‐Ching Lin, Wenyi Wang, Kuang Yu Chen et al. · New England Journal of Medicine · 2004 · 922 citations · Full text

, , +15

Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival

Jin‐Ching Lin, Jian‐Sheng Jan, Chen‐Yi Hsu et al. · Journal of Clinical Oncology · 2003 · 773 citations

, , +14

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Reginald V. Lord, Jan Brabender, David R. Gandara et al. · PubMed · 2002 · 671 citations

, , +14